share_log

HC Wainwright & Co. Upgrades Context Therapeutics to Buy, Announces $5 Price Target

Benzinga ·  Nov 1, 2023 07:17

HC Wainwright & Co. analyst Emily Bodnar upgrades Context Therapeutics (NASDAQ:CNTX) from Neutral to Buy and announces $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment